Trials / Unknown
UnknownNCT05304923
Supraglottic Jet Oxygenation and Ventilation for Gastrointestinal Endoscopy at High-altitude
Supraglottic Jet Oxygenation and Ventilation (SJOV) for Hypoxemia During Deep Sedation for Gastrointestinal Endoscopy at High-altitude
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- Sponsor
- Peking University People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study aims to determine whether the use of SOJV could reduce the rate of hypoxia during gastrointestinal endoscopic procedures in deeply sedated patients sedated at high altitude comparing to the supplemental oxygen administration via nasal cannula.
Detailed description
The participants will be randomly allocated to either SJOV or nasal cannula oxygen supply in a 1:1 ratio using block randomization with variable block sizes of four or six randomized. In the nasal cannula oxygen supply group, oxygen supplementation at 2 liters min-1 is delivered via a nasal cannula. In the SJOV group, SJOV is conducted using a Wei nasal jet tube (WNJ, Well Lead Medical Co. Ltd, Guangzhou, China) which is connected to a manual jet ventilator (Well Lead Medical Co. Ltd, Guangzhou, China) via its jet port.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Supraglottic jet oxygenation and ventilation | Supraglottic jet oxygenation and ventilation is conducted using a Wei nasal jet tube (WNJ, Well Lead Medical Co. Ltd, Guangzhou, China) which is connected to a manual jet ventilator (Well Lead Medical Co. Ltd, Guangzhou, China) via its jet port. The initial settings of SJOV are: driving pressure (DP) 15psi, respiratory rate (RR) 20 bpm, inspiratory-to-expiratory (I/E) ratio 1:2, and gas supply 100% oxygen. |
| PROCEDURE | Nasal cannula oxygen supply | Oxygen supplementation at 2 liters min-1 is delivered via a nasal cannula |
Timeline
- Start date
- 2022-04-21
- Primary completion
- 2022-08-01
- Completion
- 2022-08-01
- First posted
- 2022-03-31
- Last updated
- 2022-04-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05304923. Inclusion in this directory is not an endorsement.